Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI scans liver tumors to predict patient survival

NCT ID NCT07479264

First seen Mar 28, 2026 · Last updated May 24, 2026 · Updated 8 times

Summary

This study looked at 169 people with a type of liver cancer called intrahepatic cholangiocarcinoma. Researchers used MRI scans and computer programs to see if certain features inside the tumor could predict how long patients would live or if the cancer would come back. No new treatment was tested; the goal was to learn more about which tumor patterns are linked to better or worse outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510080, China

Conditions

Explore the condition pages connected to this study.